The demonstration that murine monoclonal antibodies to B-FN injected into tumor-bearing mice selectively accumulate in neoplastic lesions [13] prompted the generation of high-affinity human recombinant antibodies for therapeutic and diagnostic purposes [14]–[21]. Here, FN1 is linked to neoplasm.